RxDoctor Payments Data

Chris Ratcliff, OD

Optometrist · Huntington, WVNPI 1881710101

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 28.4% of the total.

$4,504in general payments, 2019–2025

Across 93 payments — averaging $48.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$1K
  • Alcon$795
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$724
  • Sun Pharmaceutical Industries Inc.$490
  • Topcon Healthcare, Inc.$343
  • LKC Technologies, Inc.$326
  • plus $548 from 11 others

What the payments were for

  • Food & beverage$4,504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,504 in reported general payments places this provider in the 85th percentile of 210 optometrist providers in West Virginia.

See all optometrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$38,098
Medicare patients
222
Services billed
4,512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Brimonidine Tartrate15$1,291
Latanoprost82$1,014
Prednisolone Acetate18$602
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat19$405
Timolol Maleate25$371
Dorzolamide Hcl21$369
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23$253

Paid to pharmacies, not to this prescriber.

Other optometrist in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →